G-protein Coupled Receptors (GPCRs): A Potential Target of Apigenin as a Novel hACE2 Receptor Specific Therapeutic for Impeding Lung Cancer Considering a Group of Missense and Nonsense Mutations in COVID-19 Patients. EJPHARMA. 2025;5(1):6-15. doi:10.24018/ejpharma.2025.5.1.85